GEN Restaurant Group Valuation
Is GENK undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of GENK when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate GENK's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate GENK's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for GENK?
Key metric: As GENK is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
| What is GENK's PE Ratio? | |
|---|---|
| PE Ratio | 49.4x |
| Earnings | US$772.00k |
| Market Cap | US$254.86m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 1x |
| Enterprise Value/EBITDA | 40.3x |
| PEG Ratio | 4.5x |
Price to Earnings Ratio vs Peers
How does GENK's PE Ratio compare to its peers?
| Company | Forward PE | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 33.7x | ||
PBPB Potbelly | 7.7x | -88.2% | US$297.0m |
NATH Nathan's Famous | 15.7x | n/a | US$343.3m |
DENN Denny's | 18.1x | 30.9% | US$320.8m |
RICK RCI Hospitality Holdings | 93.3x | 169.4% | US$462.8m |
GENK GEN Restaurant Group | 49.4x | 11.1% | US$254.9m |
Price-To-Earnings vs Peers: GENK is expensive based on its Price-To-Earnings Ratio (49.4x) compared to the peer average (33.7x).
Price to Earnings Ratio vs Industry
How does GENK's PE Ratio compare vs other companies in the US Hospitality Industry?
Price-To-Earnings vs Industry: GENK is expensive based on its Price-To-Earnings Ratio (49.4x) compared to the US Hospitality industry average (25x).
Price to Earnings Ratio vs Fair Ratio
What is GENK's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PE Ratio | 49.4x |
| Fair PE Ratio | 13.2x |
Price-To-Earnings vs Fair Ratio: GENK is expensive based on its Price-To-Earnings Ratio (49.4x) compared to the estimated Fair Price-To-Earnings Ratio (13.2x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | US$7.77 | US$13.17 +69.5% | 6.5% | US$14.00 | US$12.00 | n/a | 3 |
| Nov ’25 | US$9.03 | US$13.17 +45.8% | 6.5% | US$14.00 | US$12.00 | n/a | 3 |
| Oct ’25 | US$8.27 | US$13.17 +59.2% | 6.5% | US$14.00 | US$12.00 | n/a | 3 |
| Sep ’25 | US$9.12 | US$13.17 +44.4% | 6.5% | US$14.00 | US$12.00 | n/a | 3 |
| Aug ’25 | US$9.55 | US$13.17 +37.9% | 6.5% | US$14.00 | US$12.00 | n/a | 3 |
| Jul ’25 | US$8.67 | US$13.83 +59.6% | 1.7% | US$14.00 | US$13.50 | n/a | 3 |
| Jun ’25 | US$11.13 | US$13.83 +24.3% | 1.7% | US$14.00 | US$13.50 | n/a | 3 |
| May ’25 | US$9.80 | US$11.33 +15.6% | 16.6% | US$14.00 | US$10.00 | n/a | 3 |
| Apr ’25 | US$12.54 | US$11.33 -9.6% | 16.6% | US$14.00 | US$10.00 | n/a | 3 |
| Mar ’25 | US$7.63 | US$14.33 +87.9% | 8.7% | US$16.00 | US$13.00 | n/a | 3 |
| Feb ’25 | US$7.89 | US$15.33 +94.3% | 6.1% | US$16.00 | US$14.00 | n/a | 3 |
| Jan ’25 | US$7.83 | US$16.67 +112.9% | 15.0% | US$20.00 | US$14.00 | n/a | 3 |
| Dec ’24 | US$7.42 | US$16.67 +124.6% | 15.0% | US$20.00 | US$14.00 | n/a | 3 |
| Nov ’24 | US$8.57 | US$25.00 +191.7% | 6.5% | US$27.00 | US$23.00 | US$9.03 | 3 |
| Oct ’24 | US$11.64 | US$25.00 +114.8% | 6.5% | US$27.00 | US$23.00 | US$8.27 | 3 |
| Sep ’24 | US$16.89 | US$25.00 +48.0% | 6.5% | US$27.00 | US$23.00 | US$9.12 | 3 |
| Aug ’24 | US$19.80 | US$26.00 +31.3% | 11.3% | US$30.00 | US$23.00 | US$9.55 | 3 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.